ENTITY

TransMedics Group (TMDX US)

4
Analysis
Health CareUnited States
TransMedics Group, Inc. operates as a biotechnology company. The Company offers transplant therapy for end-stage organ failure patients across multiple disease states. TransMedics Group serves patients in the United States.
more
11 May 2025 21:28

2025 High Conviction Update: TransMedics, Cut Long Exposure and Move To the Sidelines

TransMedics, a US-based multi-organ technology platform, delivered sizable “beat and raise” in 1Q’25. I launched coverage of the stock in November...

Logo
368 Views
Share
11 Nov 2024 02:22

2025 High Conviction: TransMedics, The Market Leader and Disruptor In Organ Transplant Therapy

TransMedics, the world's leader in transforming organ transplant therapy, is my high-risk/high-reward 2025 conviction idea in healthcare sector.

Logo
336 Views
Share
24 Jan 2025 08:22Syndicated

Transmedics Group Inc (TMDX) - Thursday, Oct 24, 2024

TMDX is a high-growth med-tech company specializing in organ transplant therapy. Despite expensive traditional valuation metrics, TMDX offers a...

Logo
303 Views
Share
16 Oct 2023 08:55

GLP-1 Drugs – Are They Dessert or Time Bomb to Your Portfolio?

GLP-1s will be the next major opportunity in healthcare, which won't be limited to weight loss drugs. But when they expand new indications,...

Logo
565 Views
Share
No more insights
x